During the past decade, Slingeland Ziekenhuis conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Slingeland Ziekenhuis" #1 sponsor was "Radboud University Medical Center" with 13 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored, "Amsterdam UMC, location VUmc" with 2 trials sponsored, "Dutch Colorectal Cancer Group" with 2 trials sponsored and "Maastricht University Medical Center" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Slingeland Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 11 trials as a collaborator, "Maasstad Hospital" with 3 trials as a collaborator, "UMC Utrecht" with 3 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials as a collaborator and "Catharina Ziekenhuis Eindhoven" with 2 trials as a collaborator. Other collaborators include 95 different institutions and companies that were collaborators in the rest 100 trials.

According to Clinical.Site data, the most researched conditions in "Slingeland Ziekenhuis" are "Breast Cancer" (3 trials), "Cardiovascular Disease" (3 trials), "Heart Failure" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials) and "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "Slingeland Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Slingeland Ziekenhuis" are "Drug" (24 trials), "Other" (13 trials), "Device" (4 trials), "Procedure" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Etripamil" (2 trials), "bococizumab (PF-04950615)" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials) and "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Slingeland Ziekenhuis" are 39 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Slingeland Ziekenhuis". undefined are not yet recruiting, 13 are recruiting, 10 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 17 completed trials in Slingeland Ziekenhuis, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Slingeland Ziekenhuis, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 9 trials that are defined as “Not Applicable".